Most lately, it's been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar places as classical opioid receptors, it binds into a wide array of endogenous opioids. Contrary to most opioid receptors, this receptor functions like a scavenger and would not activate a 2